Good News! HeYou Zhizhen Hospital Approved as a Designated Medical Institution for the "Hong Kong and Macau Drug and Device Access" Policy

On December 8, 2025, the Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration officially issued a notice approving HeYou Zhizhen Hospital as a designated medical institution for the fourth batch of the “Hong Kong and Macau Drug and Device Access” policy in the Guangdong-Hong Kong-Macao Greater Bay Area. This marks a critical step for HeYou Zhizhen Hospital in aligning with international resources and serving the health of the Greater Bay Area, under the steadfast commitment to the principle of “centering on patient health needs.”

Under this policy, advanced drugs and medical devices that are clinically urgently needed and already marketed in Hong Kong and Macau but not yet available in Mainland China can, after approval, be introduced and used clinically at HeYou Zhizhen Hospital. This provides residents of the Greater Bay Area with a new pathway to access international-standard treatment and high-quality services without leaving their home region.

On December 8, 2025, the Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration jointly issued the “Notice on Publishing the List of Designated Medical Institutions for the Fourth Batch of the Hong Kong and Macau Drug and Device Access Policy in the Guangdong-Hong Kong-Macao Greater Bay Area.”

01 Policy Connectivity, Accelerating Healthcare Integration in the Greater Bay Area

The “Hong Kong and Macau Drug and Device Access” policy is an innovative initiative designed to benefit residents of the Greater Bay Area. It allows designated medical institutions to introduce and use clinically urgently needed drugs and medical devices that are already marketed in Hong Kong and Macau, enabling patients to access cutting-edge global treatment options without leaving the country.

Since its implementation, this policy has facilitated the introduction of over a hundred international new drugs and advanced medical devices, covering numerous disease treatment areas including oncology and rare diseases, bringing new hope and possibilities to tens of thousands of patients.

Since its opening on June 28, 2024, HeYou Zhizhen Hospital has placed international high standards at the core of its services. This successful selection as a designated medical institution is a significant milestone in the hospital’s ongoing commitment to this philosophy and its dedication to serving the health of Greater Bay Area residents.

02 Exceptional Capabilities, Building the Foundation for International Healthcare

The designation as a “Hong Kong and Macau Drug and Device Access” institution stems from HeYou Zhizhen Hospital’s solid professional foundation. The hospital has assembled a top-tier team of experts, led by Professor Lu Jiade and Professor Yu Xinguang, with over 90% being professor-level specialists, establishing a comprehensive diagnostic and treatment system.

The hospital is equipped with internationally advanced, high-standard medical equipment and has established a drug and device management and quality control system that strictly adheres to international benchmarks, providing a solid guarantee for the safe and compliant introduction and application of advanced drugs and devices from Hong Kong and Macau.

The hospital’s core strengths of “renowned specialists, leading technology, exceptional service, and international integration” are highly aligned with the high-quality, personalized medical needs embodied by the “Hong Kong and Macau Drug and Device Access” policy, laying the foundation for delivering outstanding medical services.

03 Embarking on a New Journey, Empowering Life-Cycle Health Management

Obtaining the “Hong Kong and Macau Drug and Device Access” qualification has injected new momentum into the international development of HeYou Zhizhen Hospital. This initiative directly benefits residents of the Greater Bay Area seeking treatment options synchronized with international standards, as well as compatriots from Hong Kong and Macau who desire homogeneous medical services.

In practical application, this policy will significantly enhance the hospital’s service capabilities in areas such as precision oncology, rare disease diagnosis and treatment, and high-end health management. Patients no longer need to travel extensively for medical care; instead, they can access innovative drugs and treatment technologies previously only available in Hong Kong and Macau through standardized channels, buying precious time in their fight against disease.

Leveraging this policy, the hospital will further deepen collaboration with top-tier medical institutions in Hong Kong, Macau, and internationally, expanding cooperation in areas such as international multidisciplinary team (MDT) consultations for complex cases, cross-border referrals, technology exchange, and talent development, thereby building a more accessible global medical resource network.

04 Looking Ahead, Co-building a Health Ecosystem in the Greater Bay Area

The acquisition of the “Hong Kong and Macau Drug and Device Access” qualification marks a new starting point for HeYou Zhizhen Hospital’s service to the Greater Bay Area strategy. Seizing this opportunity, the hospital aims not only to serve as a platform for introducing and utilizing advanced drugs and devices but also aspires to become an innovative hub for international medical technology exchange and localized application.

In the future, the hospital will focus on key therapeutic areas such as oncology and complex diseases, systematically exploring the introduction of relevant innovative drugs and devices, and establishing comprehensive patient assessment, application, and follow-up systems to ensure maximum medical value and safety.

As the integrated development of the Greater Bay Area deepens, HeYou Zhizhen Hospital will continue to leverage its distinctive advantages of high-end and international standards, combining cutting-edge global health technology with compassionate, human-centered care. This will help elevate the international level of regional medical services and contribute exceptional strength to the healthy lives of residents.

A single bay of spring water connects three regions. The bridge of policy provides another pathway for the hope of life. With a solid medical core and an international perspective, HeYou Zhizhen Hospital will transform the policy benefits of the “Hong Kong and Macau Drug and Device Access” into tangible well-being for safeguarding the health of the Greater Bay Area.